Close
Nordic 9Nordic 9

Vivo Capital (investor - Venture Capital)

United States vivocapital.com
See something wrong or missing? Let us know
Offices:Palo Alto

Vivo Capital is a global healthcare investment firm from the USA

Average round investment:52M USD
Average number per year:1.0
Distribution: 2022 (1)
Portfolio companies: United Kingdom Pulmocide
Mostly invests in: United Kingdom United Kingdom (1) Health services (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Vivo Capital

Name Criteria
Japan Asahi Kasei
73%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Bicycle Day Ventures
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Hong Kong CR-CP Life Science Fund
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany Evotec AG
73%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
China GT Healthcare Capital
73%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Integrated
73%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Adage Capital Management
73%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Negev Capital
73%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Japan Kyoritsu Holdings
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Digitalis Ventures
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top